We have demonstrated that ECM structure can strongly influence the spectrum of PRL signals and PRL-estrogen crosstalk in ER+ breast cancer cells, and reciprocally, that these hormones can modify ECM structure (Figure 2). This evidence concerns the gene ESR1 and breast carcinoma.